Mount Sinai Fuster Heart:Topics in Cardiology

1. Identify those patients with asymptomatic carotid disease in whom revascularization is warranted and be able to advise them with regard to appropriate revascularization procedure.
2. Identify those CKD patient likely to benefit from reno-protective agents and be better able to institute them in a guidelines-based manner.
3. Understand the role of left atrial occluder devices in the management of patients with atrial fibrillation and to identify those likely to benefit.

Complimentary Registration.

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-provided educational activities. All faculty participating in the planning or implementation of a provided activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material.

Mitigation of Relevant Financial Relationships

It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency, and scientific rigor in all accredited CE educational activities. All individuals in control of content of an activity accredited by ISMMS are expected to disclose all their financial relationships with ineligible companies existing within the prior 24 months. All relevant financial relationships have been mitigated and disclosed to learners before the activity takes place. 

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Michael J. Robbins, MD
Associate Professor of Medicine, Cardiology
Mount Sinai Fuster Heart
Rego Park, NY

Course Director, Faculty

Nothing to disclose

Vivek Y Reddy, MD
MOUNT SINAI MEDICAL CENTER
New York, NY

Faculty

Consulting Fee-Abbot|Consulting Fee-Biofrontera|Consulting Fee-Ablacon, Acutus Medical, Affera-Medtronic, Anumana|Consulting Fee-Apama Medical-Boston Scientific, APN Health, Aquaheart|Consulting Fee-Atacor , AtiAN, Autonomix, Axon Therapies, Backbeat |Consulting Fee-BioSig, Biosense-Webster, BioTel Heart ,Biotronik, Boston Scientific|Consulting Fee-Cairdac , CardiaCare ,Cardiofocus, Cardionomic, |Consulting Fee-CardioNXTaFTx,Circa Scientific, CoreMap|Consulting Fee-CoRISMA , Corvia Medical, Dinova-Hangzhou DiNovA EP Technology|Consulting Fee-DRS Vascular, East End Medical, EPD-Philips, EP Frontiers|Consulting Fee-Epix Therapeutics- Medtronic, EpiEP , Eximo, Farapulse-Boston Scientific|Consulting Fee-Field Medical , Fire1 , Focused Therapeutics, Gore & Associates , HRT|Consulting Fee-Impulse Dynamics, Intershunt, Javelin, Kardium, Keystone Heart, LuxMed|Consulting Fee-Manual Surgical Sciences, Medlumics, Medtronic, Middlepeak , Newpace, Novartis|Consulting Fee-Novo Nordisk, Nuvera-Biosense WebsteR, Nyra Medical, Oracle Health, Philips|Consulting Fee-Pulse Biosciences, Restore Medical, Sirona Medical, SoundCath , Surecor|Consulting Fee-Valcare and Vizaramed